Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07069517 · ClinicalTrials.gov registry record · NA
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
A NA study of Insomnia and PTSD - Post Traumatic Stress Disorder, sponsored by Palo Alto Veterans Institute for Research.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT07069517: Recruiting NA study of Insomnia and PTSD - Post Traumatic Stress Disorder, sponsored by Palo Alto Veterans Institute for Research.
NCT07069517 is a NA study of Insomnia and PTSD - Post Traumatic Stress Disorder that is actively recruiting participants, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 160 participants, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07069517, a NA study of Insomnia and PTSD - Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by Palo Alto Veterans Institute for Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a two-arm individually randomized group treatment clinical trial evaluating behavioral therapies for insomnia, nightmares, and PTSD. The study will compare cognitive-behavioral therapy for insomnia and nightmares to sleep hygiene (Control), both integrated with Written Exposure Therapy for PTSD and delivered in an accelerated (i.e., 5-day) group treatment format, preceded and followed by individual treatment sessions. 160 participants will be randomized into one of two study conditions.
Primary Outcome
Self-report measure update of the PCL designed to assess PTSD symptoms as defined by the DSM-5. Total scores range from 0-80 (higher scores indicate greater PTSD severity).
Conditions Studied
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy for Insomnia (CBTi)
- BEHAVIORAL Cognitive Behavioral Therapy for Nightmares (CBTn)
- BEHAVIORAL Written Exposure Therapy (WET)
- BEHAVIORAL Sleep Hygiene
Study Locations (1)
Texas
- Fort Hood - Kileen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-12-02 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
What NCT07069517 shows while recruiting
NCT07069517 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target.
The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 4 interventions - of which Cognitive-Behavioral Therapy for Insomnia (CBTi) is the first listed.
NCT07069517 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07069517 about?
NCT07069517 is a clinical study titled "Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD". This study is a two-arm individually randomized group treatment clinical trial evaluating behavioral therapies for insomnia, nightmares, and PTSD. The study will compare cognitive-behavioral therapy for insomnia and nightmares to sleep hygiene (Control), both integrated with Written Exposure Therapy...
What is the current status of trial NCT07069517?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-12-02. Estimated completion is 2028-12-01.
What conditions does trial NCT07069517 study?
This clinical trial studies the following conditions: Insomnia, PTSD - Post Traumatic Stress Disorder, Nightmares.
What interventions are being tested in trial NCT07069517?
The interventions under investigation include: Cognitive-Behavioral Therapy for Insomnia (CBTi) (BEHAVIORAL), Cognitive Behavioral Therapy for Nightmares (CBTn) (BEHAVIORAL), Written Exposure Therapy (WET) (BEHAVIORAL), Sleep Hygiene (BEHAVIORAL).
Who is sponsoring clinical trial NCT07069517?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07069517 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07069517's enrollment target sits among peer trials
160 45th of 151 higher than 105 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI